Treatment of SSRI-resistant depression in adolescents (TORDIA)

Trial Profile

Treatment of SSRI-resistant depression in adolescents (TORDIA)

Completed
Phase of Trial: Phase II/III

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Citalopram (Primary) ; Fluoxetine (Primary) ; Venlafaxine (Primary) ; Paroxetine; Serotonin uptake inhibitors; Trazodone
  • Indications Depression; Depressive disorders; Insomnia
  • Focus Therapeutic Use
  • Acronyms TORDIA
  • Most Recent Events

    • 17 May 2010 24 week results were published in Am J Psychiatry 2010;167:782-791.
    • 27 Feb 2008 Results have been published in JAMA v299 n8.
    • 13 Jun 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top